
浏览全部资源
扫码关注微信
收稿:2020-09-27,
纸质出版:2021-03-15
移动端阅览
朱西, 罗生军, 蒋立, 等. NPRL2与膀胱癌患者临床病理特征的相关性及对膀胱癌细胞凋亡的影响[J]. 第三军医大学学报, 2021,43(5):432-437.
Xi ZHU, Shengjun LUO, Li JIANG, et al. Correlation of NPRL2 with cinicopathological features of bladder cancer and its effect on cell apoptosis[J]. Journal of Third Military Medical University, 2021, 43(5): 432-437.
朱西, 罗生军, 蒋立, 等. NPRL2与膀胱癌患者临床病理特征的相关性及对膀胱癌细胞凋亡的影响[J]. 第三军医大学学报, 2021,43(5):432-437. DOI: 10.16016/j.1000-5404.202009233.
Xi ZHU, Shengjun LUO, Li JIANG, et al. Correlation of NPRL2 with cinicopathological features of bladder cancer and its effect on cell apoptosis[J]. Journal of Third Military Medical University, 2021, 43(5): 432-437. DOI: 10.16016/j.1000-5404.202009233.
Objective
2
To investigate the correlation between expression of NPRL2 and clinicopathological features of bladder cancer and the effect of NPRL2 silencing on the apoptosis of bladder cancer cell line Biu87/RT-4.
Methods
2
Cancer tissue samples were collected from 131 patients with bladder cancer admitted into our department from January 2014 to January 2019. The expression of NPRL2 in bladder cancer tissues was detected by immunohistochemistry
and the correlation between NPRL2 and the clinicopathological features of bladder cancer was analyzed. The expression of NPRL2 in CP-H068
Biu87 and RT-4 cell lines was detected
and the cell proliferation after NPRL2 silencing was detected by CCK-8 assay. Flow cytometry was used to detect cell apoptosis
and Western blotting to detect the expression of apoptosis-related proteins.
Results
2
NPRL2 was highly expressed in bladder cancer samples
accounting for 53.44%
and the expression was significantly correlated with the clinical stage and grade of bladder cancer (
P
<
0.05). Its expression was also obviously higher in the bladder cancer Biu87 and RT-4 cells than the normal bladder epithelial CP-H068 cells (
P
<
0.05). NPRL2 silencing resulted in decreased proliferation ability
elevated apoptotic rate
and increased protein levels of JNK
Bax and caspase-9
while decreased level of Bcl-2 in the Biu87 and RT-4 cells (
P
<
0.05).
Conclusion
2
The expression of NPRL2 is related to the clinical stage and grade of bladder cancer. Silencing NPRL2 in bladder cancer cells Biu87/RT-4 can effectively inhibit the proliferation and promote apoptosis of bladder cancer cells.
SIEGEL R L MILLER K D JEMAL A Cancer statistics, 2019 CA A Cancer J Clin 2019 69 1 7 34 10.3322/caac.21551 SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2019[J]. CA A Cancer J Clin, 2019, 69(1): 7-34. DOI:10.3322/caac.21551.
LERMAN M I MINNA J D The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes Cancer Res 2000 60 21 6116 6133 LERMAN M I, MINNA J D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes[J]. Cancer Res, 2000, 60(21): 6116-6133.
LI J WANG F HARALDSON K Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C Cancer Res 2004 61 18 6438 6443 10.1158/0008-5472.can-03-3869 LI J, WANG F, HARALDSON K, et al . Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C[J ] . Cancer Res, 2004, 64(18): 6438-6443. DOI:10.1158/0008-5472.can-03-3869.
LIU M N LIU A Y PEI F H Functional mechanism of the enhancement of 5-fluorouracil sensitivity by TUSC4 in colon cancer cells Oncol Lett 2015 10 6 3682 3688 10.3892/ol.2015.3801 LIU M N, LIU A Y, PEI F H, et al . Functional mechanism of the enhancement of 5-fluorouracil sensitivity by TUSC4 in colon cancer cells[J ] . Oncol Lett, 2015, 10(6): 3682-3688. DOI:10.3892/ol.2015.3801.
ZENG Y SHI X B YUAN Z Y Biological characteristics of renal cancer cells after CTP-mediated cancer suppressor gene NPRL2 protein treatment Biol Chem 2016 397 11 1163 1171 10.1515/hsz-2016-0143 ZENG Y, SHI X B, YUAN Z Y, et al . Biological characteristics of renal cancer cells after CTP-mediated cancer suppressor gene NPRL2 protein treatment[J ] . Biol Chem, 2016, 397(11): 1163-1171. DOI:10.1515/hsz-2016-0143.
PENG Y DAI H WANG E TUSC4 functions as a tumor suppressor by regulating BRCA1 stability Cancer Res 2015 75 2 378 386 10.1158/0008-5472.can-14-2315 PENG Y, DAI H, WANG E, et al . TUSC4 functions as a tumor suppressor by regulating BRCA1 stability[J ] . Cancer Res, 2015, 75(2): 378-386. DOI:10.1158/0008-5472.can-14-2315.
BAR-PELED L CHANTRANUPONG L CHERNIACK A D A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1 Science 2013 340 6136 1100 1106 10.1126/science.1232044 BAR-PELED L, CHANTRANUPONG L, CHERNIACK A D, et al . A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1[J ] . Science, 2013, 340(6136): 1100-1106. DOI:10.1126/science.1232044.
HUANG N CHENG S MI X Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells Mol Carcinog 2016 55 11 1613 1626 10.1002/mc.22413 HUANG N, CHENG S, MI X, et al . Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells[J ] . Mol Carcinog, 2016, 55(11): 1613-1626. DOI:10.1002/mc.22413.
CHEN Z JIANG Q ZHU P NPRL2 enhances autophagy and the resistance to everolimus in castration-resistant prostate cancer Prostate 2019 79 1 44 53 10.1002/pros.23709 CHEN Z, JIANG Q, ZHU P, et al . NPRL2 enhances autophagy and the resistance to everolimus in castration-resistant prostate cancer[J ] . Prostate, 2019, 79(1): 44-53. DOI:10.1002/pros.23709.
CHEN Z LUO S CHEN Y High expression of NPRL2 is linked to poor prognosis in patients with prostate cancer Hum Pathol 2018 76 141 148 10.1016/j.humpath.2018.02.011 CHEN Z, LUO S, CHEN Y, et al . High expression of NPRL2 is linked to poor prognosis in patients with prostate cancer[J ] . Hum Pathol, 2018, 76: 141-148. DOI:10.1016/j.humpath.2018.02.011.
LUO S SHAO L CHEN Z NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway Exp Cell Res 2020 390 2 111981 10.1016/j.yexcr.2020.111981 LUO S, SHAO L, CHEN Z, et al . NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway[J ] . Exp Cell Res, 2020, 390(2): 111981. DOI:10.1016/j.yexcr.2020.111981.
陈 欣 唐 伟 陈 志雄 NPRL2调控去势抵抗型前列腺癌对奥拉帕尼的敏感性 第三军医大学学报 2019 41 3 227 235 10.16016/j.1000-5404.201810053 https://aammt.tmmu.edu.cn/oa/DArticle.aspx?type=view&id=201810053 陈欣, 唐伟, 陈志雄, 等. NPRL2调控去势抵抗型前列腺癌对奥拉帕尼的敏感性[J]. 第三军医大学学报, 2019, 41(3): 227-235. DOI:10.16016/j.1000-5404.201810053.
CHEN X TANG W CHEN Z X Nitrogen permease regulator like-2 regulates sensitivity of castration-resistant prostate cancer to olaparib J Third Mil Med Univ 2019 41 3 227 235 10.16016/j.1000-5404.201810053 https://aammt.tmmu.edu.cn/oa/DArticle.aspx?type=view&id=201810053 CHEN X, TANG W, CHEN Z X, et al . Nitrogen permease regulator like-2 regulates sensitivity of castration-resistant prostate cancer to olaparib[J ] . J Third Mil Med Univ, 2019, 41(3): 227-235. DOI:10.16016/j.1000-5404.201810053.
ANTONI S FERLAY J SOERJOMATARAM I Bladder cancer incidence and mortality: a global overview and recent trends Eur Urol 2017 71 1 96 108 10.1016/j.eururo.2016.06.010 10.1016/j.eururo.2016.06.010 ANTONI S, FERLAY J, SOERJOMATARAM I, et al . Bladder cancer incidence and mortality: a global overview and recent trends[J ] . Eur Urol, 2017, 71(1): 96-108. DOI:10.1016/j.eururo.2016.06.010.
LIU A QIAO J HE L Nitrogen permease regulator-like-2 exhibited anti-tumor effects and enhanced the sensitivity of colorectal cancer cells to oxaliplatin and 5-fluorouracil Onco Targets Ther 2019 12 8637 8644 10.2147/ott.s219562 LIU A, QIAO J, HE L, et al . Nitrogen permease regulator-like-2 exhibited anti-tumor effects and enhanced the sensitivity of colorectal cancer cells to oxaliplatin and 5-fluorouracil[J ] . Onco Targets Ther, 2019, 12: 8637-8644. DOI:10.2147/ott.s219562.
HESSON L B COOPER W N LATIF F Evaluation of the 3p21.3 tumour-suppressor gene cluster Oncogene 2007 26 52 7283 7301 10.1038/sj.onc.1210547 HESSON L B, COOPER W N, LATIF F. Evaluation of the 3p21.3 tumour-suppressor gene cluster[J]. Oncogene, 2007, 26(52): 7283-7301. DOI:10.1038/sj.onc.1210547.
RIMKUS T SIRKISOON S HARRISON A Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers Discov Med 2017 23 128 325 330 http://forest.ckcest.cn/d/hxwx/AV_i2CstlpOm1__k1tLo.html RIMKUS T, SIRKISOON S, HARRISON A, et al . Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers[J ] . Discov Med, 2017, 23(128): 325-330.
MA Y SILVERI L LACAVA J Tumor suppressor NPRL2 induces ROS production and DNA damage response Sci Rep 2017 7 1 15311 10.1038/s41598-017-15497-0 MA Y, SILVERI L, LACAVA J, et al . Tumor suppressor NPRL2 induces ROS production and DNA damage response[J ] . Sci Rep, 2017, 7(1): 15311. DOI:10.1038/s41598-017-15497-0.
SHEN K VALENSTEIN M L GU X Arg-78 of Nprl2 catalyzes GATOR1-stimulated gtp hydrolysis by the rag GTPases J Biol Chem 2019 294 8 2970 2975 10.1074/jbc.ac119.007382 SHEN K, VALENSTEIN M L, GU X, et al . Arg-78 of Nprl2 catalyzes GATOR1-stimulated gtp hydrolysis by the rag GTPases[J ] . J Biol Chem, 2019, 294(8): 2970-2975. DOI:10.1074/jbc.ac119.007382.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621